Opportunity assessment/strategy development

• New products (including demand sensitivities)
  • Qualitative and quantitative study to understand the opportunity for two ADHD medications in a developed US market and in small EU markets
  • Demand sensitivity for several diabetes treatments, including by patient type, order of entry, and source of share (new demand versus share replacement from which product)
  • Opportunity assessment by decision point - revenue from initiatives aimed at generating additional care seeking, improved diagnosis, enhanced dosing, increased patient acceptance of medication, better compliance, etc. - for a neuropathic pain agent
  • Demand sensitivity for an osteoporosis medication
• Market dynamics (new studies / indications, new competitors, competitive assessments, etc.)
  • Impact of new entrants and new data on an existing cardiovascular medication and impact of messages / initiatives to prevent share loss
  • Impact of new entrants on a diabetes medication
• Customer groups / markets
  • Opportunity for an existing product with physicians assistants and nurse practitioners
  • Opportunity for a pain medication in 18 different specialties and across several settings (including office practices, hospitals, home health, nursing homes)
• Buying Process / patient flow / landscape studies
  • Understanding of care seeking, diagnosis, treatment, and potential leverage points for a new allergy medication
  • Identification and prioritization of visceral pain conditions based on an initial screen of 64 conditions and condition characteristics / treatment (including severity, degree of pain resolution and persistence, addressable patients, percent of time patients have pain, etc.)
  • Estimate of prevalence and documentation of care seeking, diagnosis, and treatment in fibromyalgia

Segmentation and strategic targeting

• Segmentation and targeting of physicians and consumers for an obesity medication based on their propensity to use different products and other characteristics
• Segmentation of physicians and sufferers for a pain medication based on the characteristics that are most likely to influence their purchasing behavior

Positioning / message development

• Positioning (repositioning) and message development for the world's largest medication given new clinical data and entry of competitors
• Platform development and testing for a diabetes medication

Qualitative research

• Multi-country qualitative research in sleep disorders
• Qualitative research to understand drivers of prescribing in a complex category
• Qualitative research to determine impact of payors on prescribing in a cardiovascular condition

Global research

• 10 market qualitative and quantitative study